TY - JOUR
T1 - Genetics and pathogenic mechanisms of cardiomyopathies in the Drosophila model
AU - Taghli-Lamallem, Ouarda
AU - Bodmer, Rolf
AU - Chamberlain, Jeffrey S.
AU - Cammarato, Anthony
PY - 2008/9/1
Y1 - 2008/9/1
N2 - Cardiomyopathies are diseases of heart muscle that lead to heart failure. Over the past two decades an increasing number of mutations have been identified in the pathogenesis of cardiomyopathies. Defining the physiological effects of these mutations on heart function and the mechanisms by which they activate pathogenic pathways are goals of ongoing research efforts. Currently, several studies suggest the fruit fly Drosophila is a powerful in vivo model system to study cardiac disease and, in particular, inherited cardiomyopathies. Here, we review the rationale and the utility of Drosophila for studying causal genes associated with cardiomyopathies and the mechanisms of their action.
AB - Cardiomyopathies are diseases of heart muscle that lead to heart failure. Over the past two decades an increasing number of mutations have been identified in the pathogenesis of cardiomyopathies. Defining the physiological effects of these mutations on heart function and the mechanisms by which they activate pathogenic pathways are goals of ongoing research efforts. Currently, several studies suggest the fruit fly Drosophila is a powerful in vivo model system to study cardiac disease and, in particular, inherited cardiomyopathies. Here, we review the rationale and the utility of Drosophila for studying causal genes associated with cardiomyopathies and the mechanisms of their action.
UR - http://www.scopus.com/inward/record.url?scp=67749113154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67749113154&partnerID=8YFLogxK
U2 - 10.1016/j.ddmod.2009.02.005
DO - 10.1016/j.ddmod.2009.02.005
M3 - Review article
AN - SCOPUS:67749113154
VL - 5
SP - 125
EP - 134
JO - Drug Discovery Today: Disease Models
JF - Drug Discovery Today: Disease Models
SN - 1740-6757
IS - 3
ER -